Economic TimesLean R·
Serum, Gates MRI join hands for TB vaccine
Serum Institute of India said on Thursday it would manufacture an experimental tuberculosis vaccine under an agreement with the Gates Medical Research Institute, in what is likely to be the first new TB shot in more than 100 years if approved.The novel vaccine candidate, M72/AS01E, has been in development for two decades and is currently in a late-stage clinical trial.Serum Institute plans to invest more than $100 million to scale up manufacturing capacity and prepare for future vaccine…
Read at Economic Times →
